Page 66 - Annual_Report_2016
P. 66
Financial Statements aia.gr
Statement of cash flows for the year ended 31 December 2016
Operating activities Note 2016 2015
Profit for the year before tax
Adjustments for: 5.3 189,060,866 179,843,849
Depreciation & amortisation expenses 5.14
Provision for impairment of trade receivables 5.10 74,209,512 74,401,800
Impairment loss on available-for-sale financial assets 5.4 (179,579) (2,551,052)
Net financial expenses 8,019,000
(Gain)/loss on PPE disposals 5.4 924,000
Increase/(decrease) in retirement benefits 34,190,442 38,587,191
Increase/(decrease) in provisions 5.4 (19,323)
Increase/(decrease) in other assets/liabilities 5.10 2,558
Increase/(decrease) in working capital 1,007,069 575,667
Cash generated from operations 5.19 728,752 1,181,943
Income tax paid 5.20 (8,901,399)
Interest paid (15,254,655) 26,483,479
Net cash flow from operating activities 15,334,870 310,548,036
Investment activities (30,672,973)
Acquisition of PPE 307,096,954 (32,314,338)
Interest received (46,809,451) 247,560,725
Investments to financial assets (29,745,705)
Dividends received from associate 230,541,798 (25,053,562)
Net cash flow from investment activities 542,461
Financial activities (10,520,313)
Dividends paid 446,847 27,709,248
Repayment of bank loans 286,321
Net cash flow from financial activities 125,591,501
451,719 3,484,468
Net increase/(decrease) in cash & cash equivalents
115,969,754 (87,300,000)
Cash & cash equivalents at the beginning of the year (65,274,765)
(114,600,000) (152,574,765)
Cash & cash equivalents at the end of the year (69,354,408)
The notes on pages 20 to 57 are an integral part of these financial statements. (183,954,408) 98,470,428
162,557,144 24,799,911
123,270,339 123,270,339
285,827,483
Financial Statements as at 31 December 2016 (Amounts in Euros unless otherwise stated)
19 of 57
Statement of cash flows for the year ended 31 December 2016
Operating activities Note 2016 2015
Profit for the year before tax
Adjustments for: 5.3 189,060,866 179,843,849
Depreciation & amortisation expenses 5.14
Provision for impairment of trade receivables 5.10 74,209,512 74,401,800
Impairment loss on available-for-sale financial assets 5.4 (179,579) (2,551,052)
Net financial expenses 8,019,000
(Gain)/loss on PPE disposals 5.4 924,000
Increase/(decrease) in retirement benefits 34,190,442 38,587,191
Increase/(decrease) in provisions 5.4 (19,323)
Increase/(decrease) in other assets/liabilities 5.10 2,558
Increase/(decrease) in working capital 1,007,069 575,667
Cash generated from operations 5.19 728,752 1,181,943
Income tax paid 5.20 (8,901,399)
Interest paid (15,254,655) 26,483,479
Net cash flow from operating activities 15,334,870 310,548,036
Investment activities (30,672,973)
Acquisition of PPE 307,096,954 (32,314,338)
Interest received (46,809,451) 247,560,725
Investments to financial assets (29,745,705)
Dividends received from associate 230,541,798 (25,053,562)
Net cash flow from investment activities 542,461
Financial activities (10,520,313)
Dividends paid 446,847 27,709,248
Repayment of bank loans 286,321
Net cash flow from financial activities 125,591,501
451,719 3,484,468
Net increase/(decrease) in cash & cash equivalents
115,969,754 (87,300,000)
Cash & cash equivalents at the beginning of the year (65,274,765)
(114,600,000) (152,574,765)
Cash & cash equivalents at the end of the year (69,354,408)
The notes on pages 20 to 57 are an integral part of these financial statements. (183,954,408) 98,470,428
162,557,144 24,799,911
123,270,339 123,270,339
285,827,483
Financial Statements as at 31 December 2016 (Amounts in Euros unless otherwise stated)
19 of 57
